{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:30:50Z","timestamp":1793255450673,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jad.2026.121336","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:37:14Z","timestamp":1770449834000},"page":"121336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Male sexual dysfunction associated with selective serotonin reuptake inhibitors (SSRIs): A pharmacovigilance disproportionality analysis of FAERS data"],"prefix":"10.1016","volume":"402","author":[{"given":"Shouying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2026.121336_bb0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejphar.2017.05.035","article-title":"Psychopharmacology of combined activation of the serotonin(1A) and \u03c3(1) receptors","volume":"809","author":"Ago","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.jad.2026.121336_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-024-05507-7","article-title":"The effect of drug holidays on sexual dysfunction in men treated with selective serotonin reuptake inhibitors (SSRIs) other than fluoxetine: an 8-week open-label randomized clinical trial","volume":"24","author":"Alipour-Kivi","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"Suppl. 6","key":"10.1016\/j.jad.2026.121336_bb0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00004850-199807006-00001","article-title":"Sexual problems in healthy and depressed persons","volume":"13","author":"Angst","year":"1998","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2026.121336_bb0020","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2147\/NDT.S185757","article-title":"Selective serotonin reuptake inhibitor-induced sexual dysfunction: current management perspectives","volume":"16","author":"Atmaca","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2026.121336_bb0025","article-title":"Post SSRI sexual dysfunction","volume":"7","author":"Bahrick","year":"2006","journal-title":"ASAP Tablet"},{"issue":"9","key":"10.1016\/j.jad.2026.121336_bb0030","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1176\/ajp.2006.163.9.1504","article-title":"SSRI-associated sexual dysfunction","volume":"163","author":"Balon","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2026.121336_bb0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/00926230600666410","article-title":"Genital anaesthesia persisting six years after sertraline discontinuation","volume":"32","author":"Bolton","year":"2006","journal-title":"J. Sex Marital Ther."},{"issue":"12","key":"10.1016\/j.jad.2026.121336_bb0040","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S2215-0366(21)00292-3","article-title":"Psychotropic medicine consumption in 65 countries and regions, 2008-19: a longitudinal study","volume":"8","author":"Brauer","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2026.121336_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jad.2022.08.094","article-title":"Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths","volume":"318","author":"Cao","year":"2022","journal-title":"J. Affect. Disord."},{"issue":"5","key":"10.1016\/j.jad.2026.121336_bb0050","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000447034","article-title":"The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature","volume":"85","author":"Carvalho","year":"2016","journal-title":"Psychother. Psychosom."},{"issue":"4","key":"10.1016\/j.jad.2026.121336_bb0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/13651501.2022.2057331","article-title":"General antidepressants prescribing trends 2009-2018 in Slovenia: a cross-sectional retrospective database study","volume":"26","author":"Cebron Lipovec","year":"2022","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"4","key":"10.1016\/j.jad.2026.121336_bb0060","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/14740338.2022.2007883","article-title":"Persistent sexual dysfunction after SSRI withdrawal: a scoping review and presentation of 86 cases from the Netherlands","volume":"21","author":"Chinchilla Alfaro","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jad.2026.121336_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006117.pub2","article-title":"Escitalopram versus other antidepressive agents for depression","volume":"2","author":"Cipriani","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.jad.2026.121336_bb0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000091777","article-title":"Persistent sexual side effects after SSRI discontinuation","volume":"75","author":"Csoka","year":"2006","journal-title":"Psychother. Psychosom."},{"issue":"3","key":"10.1016\/j.jad.2026.121336_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100046","article-title":"Safety in treatment: classical pharmacotherapeutics and new avenues for addressing maternal depression and anxiety during pregnancy","volume":"77","author":"Dagher","year":"2025","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.jad.2026.121336_bb0080","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJMra2034954","article-title":"Electroconvulsive therapy","volume":"386","author":"Espinoza","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jad.2026.121336_bb0085","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40264-024-01421-9","article-title":"The reporting of a disproportionality analysis for drug safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): development and statement","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf."},{"issue":"6","key":"10.1016\/j.jad.2026.121336_bb0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40264-024-01423-7","article-title":"The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): explanation and elaboration","volume":"47","author":"Fusaroli","year":"2024","journal-title":"Drug Saf."},{"key":"10.1016\/j.jad.2026.121336_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114975","article-title":"Efficacy of an adjuvant non-face-to-face multimodal lifestyle modification program for patients with treatment-resistant major depression: a randomized controlled trial","volume":"319","author":"Garcia","year":"2023","journal-title":"Psychiatry Res."},{"issue":"10312","key":"10.1016\/j.jad.2026.121336_bb0100","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(21)02143-7","volume":"398","author":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jad.2026.121336_bb0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u2013-2019: a systematic analysis for the Global Burden of Disease Study 2019","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"3 Suppl B","key":"10.1016\/j.jad.2026.121336_bb0110","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1177\/0269881198012003041","article-title":"Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomics","volume":"12","author":"Goldstein","year":"1998","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.jad.2026.121336_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41585-023-00803-5","article-title":"A clinical guide to rare male sexual disorders","volume":"21","author":"G\u00fcl","year":"2024","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.jad.2026.121336_bb0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pop.2022.10.010","article-title":"Geriatric depression","volume":"50","author":"Gundersen","year":"2023","journal-title":"Prim. Care"},{"issue":"1","key":"10.1016\/j.jad.2026.121336_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-023-05429-w","article-title":"Adjuvant administration of probiotic effects on sexual function in depressant women undergoing SSRIs treatment: a double-blinded randomized controlled trial","volume":"24","author":"Hashemi-Mohammadabad","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2026.121336_bb0130","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2026.121336_bb0135","doi-asserted-by":"crossref","DOI":"10.1017\/S2045796024000441","article-title":"Post-SSRI sexual dysfunction: barriers to quantifying incidence and prevalence","volume":"33","author":"Healy","year":"2024","journal-title":"Epidemiol. Psychiatr. Sci."},{"issue":"7","key":"10.1016\/j.jad.2026.121336_bb0140","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.24119","article-title":"Control group outcomes in trials of Psilocybin, SSRIs, or esketamine for depression: a meta-analysis","volume":"8","author":"Hieronymus","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.jad.2026.121336_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0038550","article-title":"A brief history of the development of antidepressant drugs: from monoamines to glutamate","volume":"23","author":"Hillhouse","year":"2015","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.jad.2026.121336_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081306","article-title":"Effect of selected antidepressants on placental homeostasis of serotonin: maternal and fetal perspectives","volume":"13","author":"Horackova","year":"2021","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.jad.2026.121336_bb0155","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40264-025-01560-7","article-title":"An evaluation of duplicate adverse event reports characteristics in the food and drug administration adverse event reporting system","volume":"48","author":"Janiczak","year":"2025","journal-title":"Drug Saf."},{"issue":"6","key":"10.1016\/j.jad.2026.121336_bb0160","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1039856214556323","article-title":"Management of antidepressant-induced sexual dysfunction","volume":"22","author":"Keks","year":"2014","journal-title":"Australas. Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2026.121336_bb0165","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41380-022-01824-z","article-title":"Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis","volume":"28","author":"Kishi","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2026.121336_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29693","article-title":"Global estimates on the reports of vaccine-associated myocarditis and pericarditis from 1969 to 2023: findings with critical reanalysis from the WHO pharmacovigilance database","volume":"96","author":"Lee","year":"2024","journal-title":"J. Med. Virol."},{"issue":"590","key":"10.1016\/j.jad.2026.121336_bb0175","doi-asserted-by":"crossref","first-page":"e565","DOI":"10.3399\/bjgp11X593848","article-title":"Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysis","volume":"61","author":"Lockhart","year":"2011","journal-title":"Br. J. Gen. Pract."},{"issue":"10161","key":"10.1016\/j.jad.2026.121336_bb0180","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","article-title":"Depression","volume":"392","author":"Malhi","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jad.2026.121336_bb0185","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/1673-5374.264445","article-title":"Selective serotonin reuptake inhibitors and Alzheimer\u2019s disease","volume":"15","author":"Mdawar","year":"2020","journal-title":"Neural Regen. Res."},{"issue":"10 Pt 1","key":"10.1016\/j.jad.2026.121336_bb0190","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.neubiorev.2013.01.008","article-title":"Depressive disorders and suicide: epidemiology, risk factors, and burden","volume":"37","author":"Miret","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.jad.2026.121336_bb0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/13607863.2021.2024796","article-title":"Prevalence and correlates of major depressive disorder among a national sample of middle-aged and older adults in India","volume":"27","author":"Pengpid","year":"2023","journal-title":"Aging Ment. Health"},{"issue":"7","key":"10.1016\/j.jad.2026.121336_bb0200","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1007\/s00127-024-02769-0","article-title":"Frequency of self-reported persistent post-treatment genital hypoesthesia among past antidepressant users: a cross-sectional survey of sexual and gender minority youth in Canada and the US","volume":"60","author":"Pirani","year":"2025","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.jad.2026.121336_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1651654","article-title":"Synergistic effect of Chaihu-Shugan-San combined with paroxetine tablets in the treatment of acquired premature ejaculation: study protocol for a randomized controlled proof-of-concept trial","volume":"16","author":"Qian","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.jad.2026.121336_bb0210","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/jsxmed\/qdaf094","article-title":"Efficacy and safety of pharmacological treatments in patients with premature ejaculation: an umbrella review of meta-analyses of randomized controlled trials","volume":"22","author":"Raisi","year":"2025","journal-title":"J. Sex. Med."},{"issue":"1","key":"10.1016\/j.jad.2026.121336_bb0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40264-013-0129-4","article-title":"Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis","volume":"37","author":"Reichenpfader","year":"2014","journal-title":"Drug Saf."},{"issue":"4","key":"10.1016\/j.jad.2026.121336_bb0220","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.sxmr.2017.05.002","article-title":"Sexual consequences of post-SSRI syndrome","volume":"5","author":"Reisman","year":"2017","journal-title":"Sex. Med. Rev."},{"issue":"5","key":"10.1016\/j.jad.2026.121336_bb0225","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/0092623X.2025.2495959","article-title":"Understanding the experiences of people with post-SSRI sexual dysfunction","volume":"51","author":"Rice","year":"2025","journal-title":"J. Sex Marital Ther."},{"issue":"3","key":"10.1016\/j.jad.2026.121336_bb0230","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/0269881109351966","article-title":"Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study","volume":"25","author":"Safarinejad","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jad.2026.121336_bb0235","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/YIC.0000000000000023","article-title":"A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?","volume":"29","author":"Sanchez","year":"2014","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jad.2026.121336_bb0240","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.12669\/pjms.38.5.5230","article-title":"Clinical efficacy of Vortioxetine and escitalopram in the treatment of depression","volume":"38","author":"Shao","year":"2022","journal-title":"Pak. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.jad.2026.121336_bb0245","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bjc.12333","article-title":"Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta-analysis","volume":"61","author":"Shorey","year":"2022","journal-title":"Br. J. Clin. Psychol."},{"issue":"10","key":"10.1016\/j.jad.2026.121336_bb0250","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/pds.5653","article-title":"Selective serotonin reuptake inhibitors, post-treatment sexual dysfunction and persistent genital arousal disorder: A systematic review","volume":"32","author":"Tarchi","year":"2023","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"5","key":"10.1016\/j.jad.2026.121336_bb0255","article-title":"Strategies for managing sexual dysfunction induced by antidepressant medication","volume":"2013","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10352","key":"10.1016\/j.jad.2026.121336_bb0260","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(22)01012-1","article-title":"Depression in young people","volume":"400","author":"Thapar","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jad.2026.121336_bb0265","article-title":"Disproportionality analysis of drug-induced erectile dysfunction using FAERS database","volume":"15","author":"Tian","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2026.121336_bb0270","article-title":"Trends in antidepressant use and expenditure in six major cities in China from 2013 to 2018","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2026.121336_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111428","article-title":"Dopamine D3 receptor gene is associated with obsessive-compulsive disorder and antidepressant response","volume":"140","author":"Zai","year":"2025","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726001874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032726001874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:12:22Z","timestamp":1782274342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032726001874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":55,"alternative-id":["S0165032726001874"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2026.121336","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Male sexual dysfunction associated with selective serotonin reuptake inhibitors (SSRIs): A pharmacovigilance disproportionality analysis of FAERS data","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2026.121336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121336"}}